Kang S, Lee SH, Lee HJ, Jeong H, et al. Pathological complete response, long-term outcomes, and recurrence patterns in HER2-low versus HER2-zero breast cancer after neoadjuvant chemotherapy. Eur J Cancer 2022;176:30-40.
PMID: 36183652